[Medical and dietetic management of congenital and inherited nephropathies (author's transl)].
The management of the congenital and inherited nephropathies is, still today, almost exclusively symptomatic. The authors relate the most important drugs and the dose used for the principal complications of these nephropathies: hypertension, hypo-dysprotidoemia, oedema, anemia, metabolic acidosis, polyuria, hypoevolutism, recurrent urinary infections. Particular care must be taken in order to provide an adequate caloric-protein allowance principally when the renal insufficiency is reached.
D000141:Acidosis, Renal Tubular / Q000628:therapy; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000740:Anemia / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003919:Diabetes Insipidus / Q000628:therapy; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D004487:Edema / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000628:therapy*; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000002:abnormalities; D007674:Kidney Diseases / Q000150:complications / Q000151:congenital*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D014665:Vasodilator Agents
Il trattamento medico e dietetico delle nefropatie congenite ed ereditarie.